Skip to content
10-K

Annual Report

Regenerative Medical Technology Group Inc. RMTG

0001213900-26-056841

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · May 14, 2026 13.14M sh
Shares Diluted FY 2025 · Dec 31, 2025 12.63M sh
Shares Diluted FY 2025 · Dec 31, 2024 12.53M sh
Capex FY 2025 · Dec 31, 2025 $602.58K
Capex FY 2025 · Dec 31, 2024 $215.42K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$706.52K
Operating Cash Flow FY 2025 · Dec 31, 2024 $850.7K
Cash And Equivalents FY 2025 · Dec 31, 2025 $956.72K
Cash And Equivalents FY 2025 · Dec 31, 2024 $1.17M
Stockholders Equity FY 2025 · Dec 31, 2025 −$34.75M
Stockholders Equity FY 2025 · Dec 31, 2024 −$27.36M
Stockholders Equity FY 2025 · Dec 31, 2023 −$21.8M
Current Liabilities FY 2025 · Dec 31, 2025 $36.82M
Current Liabilities restated FY 2025 · Dec 31, 2024 $28.97M
Total Liabilities FY 2025 · Dec 31, 2025 $39.23M
Total Liabilities restated FY 2025 · Dec 31, 2024 $31.18M
Current Assets FY 2025 · Dec 31, 2025 $1.22M
Current Assets FY 2025 · Dec 31, 2024 $1.25M
Total Assets FY 2025 · Dec 31, 2025 $4.49M
Total Assets FY 2025 · Dec 31, 2024 $3.82M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.62
Eps Diluted FY 2025 · Dec 31, 2024 −$0.44
Eps Basic FY 2025 · Dec 31, 2025 −$0.62
Eps Basic FY 2025 · Dec 31, 2024 −$0.44
Net Income FY 2025 · Dec 31, 2025 −$7.81M
Net Income FY 2025 · Dec 31, 2024 −$5.56M
Operating Income FY 2025 · Dec 31, 2025 −$867.16K
Operating Income FY 2025 · Dec 31, 2024 $81.18K
Gross Profit FY 2025 · Dec 31, 2025 $2.81M
Gross Profit FY 2025 · Dec 31, 2024 $2.82M
Cost Of Revenue FY 2025 · Dec 31, 2025 $2.29M
Cost Of Revenue FY 2025 · Dec 31, 2024 $1.28M
Revenue FY 2025 · Dec 31, 2025 $5.1M
Revenue FY 2025 · Dec 31, 2024 $4.11M
Long Term Debt FY 2025 · Aug 14, 2025 $4